DOPRAM

This brand name is authorized in United States. It is also authorized in France, Japan, Malta, Netherlands, Romania, UK.

Active ingredients

The drug DOPRAM contains one active pharmaceutical ingredient (API):

1	Doxapram UNII P5RU6UOQ5Y - DOXAPRAM HYDROCHLORIDE
	Doxapram is an analeptic agent (a stimulant of the central nervous system). Doxapram produces respiratory stimulation mediated through the peripheral carotid chemoreceptors. It is thought to stimulate the carotid body by inhibiting certain potassium channels. Used as temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease.
	Read more about Doxapram

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DOPRAM Solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)
DOPRAM Sterile solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R07AB01	Doxapram	R Respiratory system → R07 Other respiratory system products → R07A Other respiratory system products → R07AB Respiratory stimulants
Discover more medicines within R07AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	68296666
JP	医薬品医療機器総合機構	2219400A1031
MT	Medicines Authority	AA1411/02501, AA565/32502
NL	Z-Index G-Standaard	13651471
NL	Z-Index G-Standaard, PRK	202061
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69245001
US	FDA, National Drug Code	0641-6018